IOL CHEMICALS AND PHARMACEUTICALS
|
IOL CHEMICALS AND PHARMACEUTICALS Last 5 Year Financial Ratios History
[Consolidated]
Mar2023 | Mar2022 | |
---|---|---|
Operational & Financial Ratios | ||
Earnings Per Share (Rs) | 23.70 | 28.56 |
CEPS(Rs) | 31.56 | 35.93 |
DPS(Rs) | 4.00 | 4.00 |
Book NAV/Share(Rs) | 256.81 | 237.15 |
Tax Rate(%) | 26.24 | 25.43 |
Margin Ratios | ||
Core EBITDA Margin(%) | 10.18 | 11.83 |
EBIT Margin(%) | 9.25 | 10.67 |
Pre Tax Margin(%) | 8.51 | 10.30 |
PAT Margin (%) | 6.28 | 7.68 |
Cash Profit Margin (%) | 8.36 | 9.66 |
Performance Ratios | ||
ROA(%) | 6.80 | 8.28 |
ROE(%) | 9.60 | 12.04 |
ROCE(%) | 13.57 | 16.25 |
Asset Turnover(x) | 1.08 | 1.08 |
Sales/Fixed Asset(x) | 2.52 | 2.87 |
Working Capital/Sales(x) | 4.78 | 3.85 |
Efficiency Ratios | ||
Fixed Capital/Sales(x) | 0.40 | 0.35 |
Receivable days | 80.26 | 78.51 |
Inventory Days | 60.53 | 68.50 |
Payable days | 85.35 | 95.12 |
Valuation Parameters | ||
PER(x) | 11.94 | 12.39 |
PCE(x) | 8.96 | 9.85 |
Price/Book(x) | 1.10 | 1.49 |
Yield(%) | 1.41 | 1.13 |
EV/Net Sales(x) | 0.78 | 0.91 |
EV/Core EBITDA(x) | 6.84 | 6.82 |
EV/EBIT(x) | 8.38 | 8.49 |
EV/CE(x) | 0.83 | 0.98 |
M Cap / Sales | 0.75 | 0.95 |
Growth Ratio | ||
Net Sales Growth(%) | 1.52 | - |
Core EBITDA Growth(%) | -13.45 | - |
EBIT Growth(%) | -12.02 | - |
PAT Growth(%) | -17.02 | - |
EPS Growth(%) | -17.02 | - |
Financial Stability Ratios | ||
Total Debt/Equity(x) | 0.05 | 0.03 |
Current Ratio(x) | 1.92 | 1.99 |
Quick Ratio(x) | 1.28 | 1.27 |
Interest Cover(x) | 12.45 | 28.12 |
Total Debt/Mcap(x) | 0.05 | 0.02 |
Compare Financial Ratios of peers of IOL CHEMICALS AND PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
IOL CHEMICALS AND PHARMACEUTICALS | ₹2,257.6 Cr | -6.2% | -9.5% | 37.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
IOL CHEMICALS AND PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
IOL CHEMICALS AND PHARMACEUTICALS | -6.2% |
-9.5% |
37.5% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses